Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Direct Xa inhibitors in acute coronary syndrome.

Ikutomi M, Nakamura F.

Circ J. 2013;77(9):2246-8. Epub 2013 Jul 31. No abstract available.

2.

Apixaban with antiplatelet therapy after acute coronary syndrome.

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators..

N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819. Epub 2011 Jul 24.

3.

Randomized, double-blind trial to evaluate the safety of apixaban with antiplatelet therapy after acute coronary syndrome in Japanese patients (APPRAISE-J).

Ogawa H, Goto S, Matsuzaki M, Hiro S, Shima D; APPRAISE-J investigators..

Circ J. 2013;77(9):2341-8. Epub 2013 Jun 7.

4.

Apixaban in acute coronary syndromes.

Karthikeyan G, Eikelboom JW.

Cardiovasc Ther. 2011 Oct;29(5):285-90. doi: 10.1111/j.1755-5922.2010.00195.x. Epub 2010 Jun 11. Review.

PMID:
20553278
5.

Apixaban after acute coronary syndrome.

Fauchier L, Clementy N.

N Engl J Med. 2011 Nov 10;365(19):1844; author reply 1844-5. doi: 10.1056/NEJMc1111422#SA1. No abstract available.

PMID:
22070491
6.

Apixaban in other situations?

[No authors listed]

Prescrire Int. 2012 Sep;21(130):203. No abstract available.

PMID:
23016248
7.

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

APPRAISE Steering Committee and Investigators., Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, Dellborg M, Fox KA, Goodman SG, Harrington RA, Huber K, Husted S, Lewis BS, Lopez-Sendon J, Mohan P, Montalescot G, Ruda M, Ruzyllo W, Verheugt F, Wallentin L.

Circulation. 2009 Jun 9;119(22):2877-85. doi: 10.1161/CIRCULATIONAHA.108.832139. Epub 2009 May 26.

8.

The Challenge of Getting it Just Right: Optimizing Long-Term Antithrombotic Therapy After Acute Coronary Syndrome.

Ruff CT.

J Am Coll Cardiol. 2015 Aug 18;66(7):788-90. doi: 10.1016/j.jacc.2015.06.1082. No abstract available.

9.

[Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation].

Geisler T, Gawaz M.

MMW Fortschr Med. 2011 Apr 14;153(15):27-30; quiz 31. German. No abstract available.

PMID:
21667556
10.

Minimizing the risks of anticoagulants and platelet inhibitors.

Alexander KP, Peterson ED.

Circulation. 2010 May 4;121(17):1960-70. doi: 10.1161/CIRCULATIONAHA.109.853135. Review. No abstract available.

11.

Clopidogrel. Bleeding and resistance.

Ball J.

BMJ. 2009 May 20;338:b1927. doi: 10.1136/bmj.b1927. No abstract available.

PMID:
19457954
12.

Ticagrelor versus clopidogrel in acute coronary syndromes.

Wartak SA, Lotfi A, Rothberg M.

N Engl J Med. 2009 Dec 10;361(24):2386-7; author reply 2387-8. No abstract available.

PMID:
20050198
13.

The score is in but is the decision final?

Brinker J.

J Am Coll Cardiol. 2010 Jun 8;55(23):2567-9. doi: 10.1016/j.jacc.2010.02.037. No abstract available.

14.

New oral anticoagulants after acute coronary syndrome.

Bennaghmouch N, Ten Berg JM.

Best Pract Res Clin Haematol. 2013 Jun;26(2):141-50. doi: 10.1016/j.beha.2013.07.006. Epub 2013 Jul 22. Review.

PMID:
23953902
15.

Fine-tuning therapy for acute coronary syndromes.

Fuster V.

N Engl J Med. 2010 Sep 2;363(10):976-7. doi: 10.1056/NEJMe1008891. No abstract available.

PMID:
20818910
16.

The year in non-ST-segment elevation acute coronary syndrome.

Giugliano RP, Braunwald E.

J Am Coll Cardiol. 2008 Sep 23;52(13):1095-103. doi: 10.1016/j.jacc.2008.07.005. Review. No abstract available.

17.

Predictors of bleeding in acute coronary syndromes with clopidogrel and prasugrel.

Rodriguez L, Conde D, Lalor N, Elissamburu P, Trivi M.

Am J Emerg Med. 2013 Aug;31(8):1287. doi: 10.1016/j.ajem.2013.05.025. Epub 2013 Jun 14. No abstract available.

PMID:
23769852
18.

Ticagrelor versus clopidogrel in acute coronary syndromes.

Cattaneo M.

N Engl J Med. 2009 Dec 10;361(24):2386; author reply 2387-8. No abstract available.

PMID:
20050197
19.

Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.

Gutierrez A, Rao SV.

Cleve Clin J Med. 2010 Jun;77(6):369-79. doi: 10.3949/ccjm.77a.09142.

20.

Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: a pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY.

Chan MY, Sun JL, Wang TY, Lopes RD, Jolicoeur ME, Pieper KS, Rao SV, Newby LK, Mahaffey KW, Harrington RA, Peterson ED.

Am Heart J. 2010 Dec;160(6):1056-64, 1064.e2. doi: 10.1016/j.ahj.2010.09.001.

PMID:
21146658

Supplemental Content

Support Center